United States · FDA National Drug Code directory
Zolmitriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-715_c8bbe1ff-34e4-4638-ac8a-00b1ceb2f310
- Product NDC
- 68382-715
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Zolmitriptan
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130516
- Source listing expiry
- 20261231
Source-listed ingredients
- ZOLMITRIPTAN — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68382-715-01) · 68382-715-01
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68382-715-06) · 68382-715-06
- 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68382-715-10) · 68382-715-10
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68382-715-16) · 68382-715-16
- 10 BLISTER PACK in 1 CARTON (68382-715-77) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (68382-715-30) · 68382-715-77
- 1 BLISTER PACK in 1 CARTON (68382-715-86) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (68382-715-69) · 68382-715-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →